Autocrine Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2 Growth Pathway Represents a Cyclooxygenase-2-Independent Target for the Cyclooxygenase-2 Inhibitor NS-398 in Colon Cancer Cells

Publisher： Karger

E-ISSN： 1423-0232|68|2-3|204-211

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.2-3, 2005-07, pp. : 204-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Catechins inhibit vascular endothelial growth factor production and cyclooxygenase‐2 expression in human dental pulp cells

By  

INTERNATIONAL ENDODONTIC JOURNAL, Vol. 48, Iss. 3, 2015-03 ,pp. : 277-282

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Significance of Vascular Endothelial Growth Factor and Cyclooxygenase-2 in Patients with Rectal Cancer Treated with Preoperative Radiotherapy

By  

Oncology, Vol. 71, Iss. 5-6, 2007-08 ,pp. : 312-319

Karger

Access to resources Recommend Favorite

Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase‐2 and vascular endothelial growth factor expression

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 5, 2015-07 ,pp. : 458-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Angiogenic Switch for Vascular Endothelial Growth Factor-A and Cyclooxygenase-2 in Prostate Carcinoma: Correlation with Microvessel Density, Androgen Receptor Content and Gleason Grade

By  

Urologia Internationalis, Vol. 87, Iss. 4, 2011-09 ,pp. : 464-469

Karger

Access to resources Recommend Favorite

Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway

By  

THE JOURNAL OF PATHOLOGY, Vol. 236, Iss. 4, 2015-08 ,pp. : 407-420

John Wiley & Sons Inc

Access to resources Recommend Favorite